These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 30270447)

  • 1. Decreased regulatory function of CD4
    Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
    Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients.
    Parackova Z; Kayserova J; Danova K; Sismova K; Dudkova E; Sumnik Z; Kolouskova S; Lebl J; Stechova K; Sediva A
    Autoimmunity; 2016 Dec; 49(8):523-531. PubMed ID: 27560779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
    Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
    Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
    Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
    Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD4+CD25+Foxp3+ Regulatory T Cells, Interleukin 10 and Transforming Growth Factor β in Newly Diagnosed Type 2 Diabetic Patients.
    Yuan N; Zhang HF; Wei Q; Wang P; Guo WY
    Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):96-101. PubMed ID: 28954308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
    Wang R; Huang K
    Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL4 promoted the production of CD4
    Xu T; Zhao J; Wang X; Meng Y; Zhao Z; Bao R; Deng X; Bian J; Yang T
    Autoimmunity; 2020 Aug; 53(5):289-296. PubMed ID: 32538218
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
    Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
    Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced CD4
    Mirzakhani M; Shahbazi M; Akbari R; Oliaei F; Asgharpour M; Nikoueinejad H; Mohammadnia-Afrouzi M
    Transpl Immunol; 2020 Jun; 60():101290. PubMed ID: 32240775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2.
    Kulhankova K; Rouse T; Nasr ME; Field EH
    PLoS One; 2012; 7(9):e43609. PubMed ID: 22984435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The phenotype and function of CD4+ CD25+ regulatory T cells in hepatitis B patients].
    Fu JL; Xu DP; Shi M; Zhang H; Jin L; Tang ZR; Wang FS
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):642-5. PubMed ID: 17074148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feedback loop of immune regulation by CD4+CD25+ Treg.
    Jung YJ; Seoh JY
    Immunobiology; 2009; 214(4):291-302. PubMed ID: 19327546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction.
    Liu X; Gao N; Li M; Xu D; Hou Y; Wang Q; Zhang G; Sun Q; Zhang H; Zeng X
    PLoS One; 2013; 8(6):e64531. PubMed ID: 23776439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal cells recruit and regulate T regulatory cells.
    Di Ianni M; Del Papa B; De Ioanni M; Moretti L; Bonifacio E; Cecchini D; Sportoletti P; Falzetti F; Tabilio A
    Exp Hematol; 2008 Mar; 36(3):309-18. PubMed ID: 18279718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
    Wang ZH; Zhu JY; Li T; Leng XS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased suppression of CD8
    Giri PS; Dwivedi M; Begum R
    Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced frequency and functional potency of CD49d
    Borzouei S; Mohamadtaheri M; Zamani A; Behzad M
    Immunobiology; 2021 Jul; 226(4):152113. PubMed ID: 34247018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.